India can generate a staggering $774 billion revenue and create 12 million jobs impacting 1.5 billion lives by 2030 with an investment of $217 billion in healthcare and allied sectors, according to a report. The collaborative report titled Investing for Impact: Healthcare, Pharma & Healthtech has been put together by Aspire Circle, India’s foremost impact leadership champion and advocate with the help of 21 co-authors and six guest contributors, with Capgemini as the key sponsor.

Primary and preventive healthcare will be the biggest market at $274 billion by 2030 followed by drug and vaccine manufacturing at $120 billion, the latter catalysed by vaccine manufacturers and over eight Pharma IPOs in the last two years, mobilising Rs 10K crore. Spurred by >$5 billion in COVID-19 testing alone to date, as well as the increased attention to preventive care, diagnostic services will grow to a $60 bn market by 2030.

The report spells out India’s top ten outstanding investment ideas, being shaped by new-age technologies, innovative business models, delivery platforms and regulatory environment: preventive and primary healthcare; pharma, drug and vaccine manufacturing; screening, diagnostics and testing; affordable healthcare and operational efficiency; medical tourism; E Healthcare and telecare; health insurance and innovative impact financing; E-Pharmacies; medical workforce education and skilling and gene therapy.